At the committee meeting, she said that Trump has already axed over 800 grants and billions of dollars in research funding, ...

According to the Elsevier 2024 Gender Equality in Research & Innovation Report, women researchers are well-represented across ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic ...

In its update, GSK reported a 17% rise in speciality medicines across its HIV, cancer and respiratory business to £2.93 ...

Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...

AZ has already thrown down a marker for its tougher stance on Europe with an earlier decision to abandon a $560 million vaccine manufacturing plant initially intended for the UK, sparking speculation ...

Abstract 1679, under the session ‘Drug Combination Strategies for Cancer Treatment’, showed that APG-2449, a novel focal ...

Italfarmaco's oral HDAC inhibitor Duvyzat has been recommended for approval in the EU as a treatment for Duchenne muscular ...

The UK’s Voluntary Scheme for Branded Medicines Pricing and Access ( VPAG) was agreed upon by the ABPI, the research-based ...

Lawyers for Todd Engel, 62, filed suit yesterday in New Jersey superior court. According to the complaint, Engel is now ...

In addition, HHS Secretary Robert F. Kennedy Jr addressed the delay in Novavax's approval in a CBS interview earlier this ...